Precision BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	34.26	68.7	48.73	25.1	115.53
Revenue Growth (YoY)	-50.12%	40.98%	94.15%	-78.28%	375.72%
Gross Profit	34.26	68.7	48.73	25.1	115.53
Selling, General & Admin	-32.24	-35.3	-39.09	-41.28	-39.67
Research & Development	-54.17	-59.56	-53.38	-46.12	-115.24
Other Operating Expenses	0.04	-	-	-	-
Total Operating Expenses	-86.38	-94.86	-92.46	-87.41	-154.91
Operating Income	120.64	163.55	141.19	112.5	270.43
Total Non-Operating Income (Expense)	5.54	33.33	1.21	-10.6	8.77
Pretax Income	126.18	196.88	142.4	101.9	279.21
Net Income	-45.72	7.17	142.4	-111.64	-30.6
Earnings From Discontinued Operations	0.89	-	-	-	-
Net Income to Common	-45.72	7.17	142.4	-111.64	-30.6
Net Income Growth	-	-94.97%	-	-	-
Shares Outstanding (Basic)	13	7	4	3	2
Shares Outstanding (Diluted)	13	7	4	3	2
Shares Change (YoY)	86.32%	79.20%	31.11%	49.77%	12.79%
EPS (Basic)	-3.56	1.05	-15.96	-38.10	-15.60
EPS (Diluted)	-3.56	1.04	-15.96	-38.10	-15.60
Shares Outstanding	24.09	8.2	4.19	3.7	2.03
Free Cash Flow	-65.93	-58.7	-86.07	-49.07	-15.91
Free Cash Flow Per Share	-5.14	-8.53	-22.41	-16.75	-8.13
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	352.09%	238.08%	289.76%	448.26%	234.08%
Profit Margin	368.25%	286.60%	292.24%	406.02%	241.68%
FCF Margin	-192.41%	-85.44%	-176.64%	-195.52%	-13.77%
EBITDA	122.11	166.96	148.01	120.3	279.42
EBITDA Margin	356.37%	243.04%	303.75%	479.33%	241.86%
EBIT	120.64	163.55	141.19	112.5	270.43
EBIT Margin	352.09%	238.08%	289.76%	448.26%	234.08%

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q